Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion type Assertion NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_head.
- NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion description "[ PTCs with METE without NMP have an extremely low recurrence rate in contrast to tumors with gross ETE. (ii) High mitotic activity and/or tumor necrosis confers worse DSS even in patients stratified for gross ETE in trachea/esophagus. (iii) BRAF positivit]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_provenance.
- NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion evidence source_evidence_literature NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_provenance.
- NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion SIO_000772 20860430 NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_provenance.
- NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion wasDerivedFrom gad-20150221 NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_provenance.
- NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_assertion wasGeneratedBy ECO_0000203 NP102770.RATHdifS7DTtgAZ4VM46iEqA-s9tcc7_36HdMoYa4VDp0130_provenance.